Home/Filings/4/0001140361-23-035207
4//SEC Filing

Ahmad Qasim Iftikhar 4

Accession 0001140361-23-035207

CIK 0001865494other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 4:20 PM ET

Size

5.2 KB

Accession

0001140361-23-035207

Insider Transaction Report

Form 4
Period: 2023-07-17
Ahmad Qasim Iftikhar
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-17+288,153288,153 total
    Exercise: $1.86Exp: 2033-07-17Common Stock (288,153 underlying)
Footnotes (1)
  • [F1]One-fourth of these options vest on July 17, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Documents

1 file

Issuer

IO Biotech, Inc.

CIK 0001865494

Entity typeother

Related Parties

1
  • filerCIK 0001985801

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:20 PM ET
Size
5.2 KB